Teladoc Health grants 37,425 RSUs to director

Anquillare Mark V reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 08/04/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Anquillare Mark V reported acquisition or exercise transactions in this Form 4 filing.

Teladoc Health, Inc. reported that director Mark V. Anquillare received a grant of 37,425 Restricted Stock Units on 2026-08-03, each representing a contingent right to one share of common stock. One-third of the units vest on the first anniversary of the grant, with the remainder vesting in eight substantially equal quarterly installments, leaving him with 37,425 RSUs directly held after the award.

Insider Trade Summary

Grant/Award: 37,425 shares

Grant/Award 1 txn

Insider Anquillare Mark V

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2	37,425	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 37,425 contracts (Direct)

Holdings Before and After: Restricted Stock Units, 0 to 37,425 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
2. F2. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

RSUs granted: 37425.0000 RSUs Grant price per unit: 0.0000 per RSU RSUs following transaction: 37425.0000 RSUs +1 more

4 metrics

RSUs granted 37425.0000 RSUs Restricted Stock Units granted to director on 2026-08-03

Grant price per unit 0.0000 per RSU Reported transaction price for the RSU award

RSUs following transaction 37425.0000 RSUs Total Restricted Stock Units directly held after the grant

Transaction date 2026-08-03 Date of the RSU grant to the director

Key Terms

Restricted Stock Units, contingent right, vest, underlying security

4 terms

Restricted Stock Units financial

"security_title: Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

vest financial

"One-third of the restricted stock units vest on the first anniversary"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

underlying security financial

"underlying_security_title: Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did Teladoc Health (TDOC) grant to Mark V. Anquillare?

Teladoc Health granted director Mark V. Anquillare 37,425 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Teladoc Health common stock, providing him with equity-based compensation aligned with the company’s future share performance.

When was the new RSU grant to the Teladoc Health (TDOC) director made?

The RSU grant to Mark V. Anquillare was dated 2026-08-03. This date starts the vesting timeline for the award, which includes an initial one-year cliff vest followed by additional vesting in substantially equal quarterly installments.

How do the 37,425 Teladoc Health (TDOC) RSUs vest for Mark V. Anquillare?

For this award, one-third of the 37,425 RSUs vest on the first anniversary of the grant. The remaining RSUs then vest in eight substantially equal quarterly installments, spreading vesting over an additional two years after the initial cliff period.

What is the price per unit for Mark V. Anquillare’s Teladoc Health (TDOC) RSU grant?

The reported transaction price per RSU is $0.0000 per unit. This reflects that the grant is a compensatory equity award, not a market purchase, and does not require the director to pay a cash exercise price for the underlying common shares.

How many Teladoc Health (TDOC) RSUs does Mark V. Anquillare hold after this grant?

Following this grant, Mark V. Anquillare is reported as directly holding 37,425 Restricted Stock Units. These RSUs, once vested and settled, would deliver an equivalent number of Teladoc Health common shares, subject to the award’s vesting schedule and other applicable terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anquillare Mark V

(Last) (First) (Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/03/2026		A		37,425		(2)	(2)	Common Stock	37,425	$0	37,425	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

2. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)